Most patients with limb pain and no alternative explanation have a diagnosis. These patients can often be treated with anti-inflammatory medications and/or physiotherapy, and the pain often disappears. While this intervention can produce relief for some people, the high success rate is the same without these interventions, supporting the view that limb pain is a common complaint, for which diagnosis and treatment is normal.
A few treatments are commonly used to treat limb pain, and the treatments are usually effective. For example, some treatments, such as NSAIDs and muscle relaxants, can be used to assist with muscle soreness. Furthermore, some patients may benefit from surgery to help alleviate pain.\n\n- Sores\n- Fungus infection\n\n- Pregnant or lactating women should avoid salicylates. (Specifically, salicylic acid in any form.)\n\nA small amount of aspirin is often recommended by doctors for protection against heart attacks. However, over 40% of people taking aspirin for at least 21 days develop severe bleeding.
Limb pain, particularly ipsilateral limb pain, is most often caused by inter-articular pathology. Chronic compartment syndrome may also cause chronic limb pain or may develop into such a condition. The mechanism of pain production in this group is unknown.
Limp pain and arthritis were classified by ICD-9, implying an overlap between diagnoses. These two entities represent a considerable burden to patients in the United States. The actual number of limb pain and arthritis cases is most likely to be at least double the number reported in this study.
Patients with peripheral (as well as central) pain and functional limitation resulting from [spinal cord injury](https://www.withpower.com/clinical-trials/spinal-cord-injury) have variable neurologic recovery following stimulation of different nerves. There is scant evidence comparing what patients experience after treatment with spinal cord stimulation.
This article presents the current data on the first clinical trial involving SCS conducted by the U.S. Veterans Health Administration. Although the trial was designed to confirm preliminary findings in previous studies and to compare current SCS devices to one another, a trend toward reduced pain scores was not observed. Further research in this area is warranted before SCS is recommended for widespread application.
A large number of new drugs have been developed in recent years, and limb pain remains a challenge for pain relief. Recent studies of non-analgesic nonsteroidal anti-inflammatory drugs have found them to be ineffective in relieving the pain of limb pain.
In this large cohort of patients, an array of both common and adverse effects is reported. As this study does not encompass the full range of this side effect spectrum, it is important that other centers performing SCS use patient-centered protocols and/or standardized rating systems to assure consistency of care, outcomes, and side effect reporting.
SCS may be a viable treatment option for people with refractory chronic pain in a small number of patients. However, the safety of SCS remains unknown and awaits further large randomized controlled trials. SCS should not be considered a treatment option until the safety profile is clearly established.
Stimulating the S1 area with an implantable pulse generator may be effective in reducing axial pain in a majority of patients without obvious complications and has been well tolerated. Spinal cord stimulation may be an effective treatment for axial pain due to radicular pain resulting from an upper limb problem.